SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
PCCW Limited (PCCWY) , forward earnings yield 13.81%. PEG 0.20 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
- Forward P/E 7.2
- PEG Ratio 0.20 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
Overall SharesGrow Score: 20/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — PCCWY
Valuation Multiples
P/E (TTM)0.0
Forward P/E7.2
PEG Ratio0.20
Forward PEG0.20
P/B Ratio0.00
P/S Ratio0.15
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.33
Forward EPS (Est.)$1.06
Book Value / Share$0.00
Revenue / Share$51.95
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield13.81%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$2.70 |
$38.38B |
$2.05B |
5.3% |
| 2017 |
$2.60 |
$37.05B |
$2.25B |
6.1% |
| 2018 |
$1.20 |
$38.85B |
$897M |
2.3% |
| 2019 |
$3.70 |
$37.52B |
$2.87B |
7.6% |
| 2020 |
$0.84 |
$38.05B |
$649M |
1.7% |
| 2021 |
$3.70 |
$38.65B |
$2.85B |
7.4% |
| 2022 |
$-0.80 |
$36.07B |
$393M |
1.1% |
| 2023 |
$-0.61 |
$36.35B |
$-236M |
-0.6% |
| 2024 |
$-0.39 |
$37.56B |
$-66M |
-0.2% |
| 2025 |
$-0.33 |
$40.18B |
$-26.95M |
-0.1% |
